C-6161

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameC-6161
Drug Alias NameC-6161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDepressive Disorder, MajorParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Mental Health (Nimh)Merck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A